PMTC2013


Go to content

Program - old

Preliminary Program


(As of September 2012)

Thursday, 31 January 2013

09.00 - 10.00

Opening Ceremony

10.00 - 10.45

Stephen Friend (Sage Bionetworks, Seattle, WA, USA)
The marriage between “Translational Medicine” and “Big Data”: Opportunities to shift how we do science together

10.45 - 11.00

Jean Paul Thiéry (Institute of molecular and cell biology, Singapore)
Therapeutic strategies in carcinoma based on the epithelial mesenchymal transition concept

11.00 - 11.45

Johan Hanson (Karolinska Institute, Stockolm, Sweden)
Overcoming the chemioresistance

11.45 - 12.30

Alex Eggermont (Institut Gustave Roussy, Villejuif, France)
Targeted therapy for melanoma

12:30 - 14:00

Lunch

14:00 - 14:45

Cesary Szczylik (Warsaw, Poland)
Advances in molecular diagnostic and treatment of metastatic renal cell carcinoma

14:45 - 15:30

Jean Yves Blay (Centre Léon Bérard, Lyon, France)
Targeted therapy of connective tissue tumors hitting the driver

15:30 - 16:15

Jean-Pierre Armand (Institut Gustave Roussy, Villejuif, France)
Anti angiogenic components in development

15:30 - 17:00

Laurence Albigès (Institut Gustave Roussy, Villejuif, France)
New targets in non-clear cell renal carcinoma

   

Friday, 1 February 2013

08.30 - 09.15

Samir M. Hanash (Fred Hutchinson Cancer Res. Center, Seattle, WA, USA)
Fast tracking the development of cancer biomarkers using proteomics

09.15 - 10:00

Vladimir Lazar (Institut Gustave Roussy, UGF, Villejuif, France)
New methods and computational tools to predict efficacy of cancer individualised therapeutics

10:00 - 10:45

Charles Swanton (Department of Medical Oncology, London, UK)
Intratumour heterogeneity: implications for personalised medicine

10:45 - 11:00

Coffee break

11:00 - 11:45

Samir Khleif: (NIH Bethesda, USA)
Targeting cancer with vaccines

11:45 - 12:30

Ali Abdulrazek (Gulf Oncology Center, Sharjah, UAE)
Overview on cancer in the Gulf Region

12:30 - 13:15

Alain Gouyette (Pharmacy school, Chatenay-Malabry, France)
How to prepare patients to targeted therapy?

13:15

Friday Prayer & Lunch

   

Saturday, 2 February 2013

08.30 - 09.15

Manel Esteller (IDIBELL, Barcelona, Spain)
Epigenetics in Personalized Cancer Medicine

09.15 - 10:00

Fabrice Andre (Insitut Gustave Roussy, Villejuif, France)
Molecular portraits of breast cancer: application to prognosis and therapeutic sensitivity

10:00 - 10:45

Nathalie Lassau MD, PhD (Institut Gustave Roussy, Villejuif, France)
The dynamic contrast enhanced ultrasonographya potential predictive marker for personalized medicine?

10:45 - 11:00

Coffee break

11:00 - 11:45

Waun Ki Hong (MD Anderson Cancer Center, Houston, Texas)
Personalized targeted therapy and prevention in lung cancer

11:45 - 12:30

Pr Seiji Yano (Cancer Research Institute, Kanazawa Univ, Japan)
Mechanisms of resistance to molecular targeted drugs in lung cancer and personalized medicine

12:30 - 13:15

Fabien Calvo (INCA, Boulogne Billancourt, France)
Personalized medicine: a nation wide initiative for an equal access to cancer treatment

13:15

Lunch


Back to content | Back to main menu